M.V. Mateos

1.2k total citations
15 papers, 557 citations indexed

About

M.V. Mateos is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, M.V. Mateos has authored 15 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in M.V. Mateos's work include Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). M.V. Mateos is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). M.V. Mateos collaborates with scholars based in Spain, United States and Switzerland. M.V. Mateos's co-authors include Sergio Giralt, Kenneth C. Anderson, Shaji Kumar, Robert Z. Orlowski, Chor Sang Chim, Paul G. Richardson, Morie A. Gertz, Xavier Leleu, Gordon Cook and Jesús F. San Miguel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

M.V. Mateos

15 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.V. Mateos Spain 9 358 286 269 132 79 15 557
Rafael Martínez Spain 8 252 0.7× 173 0.6× 168 0.6× 122 0.9× 123 1.6× 16 428
Τατιάνα Τζένου Greece 12 200 0.6× 123 0.4× 179 0.7× 128 1.0× 145 1.8× 26 394
Neil Palmisiano United States 13 162 0.5× 228 0.8× 156 0.6× 128 1.0× 54 0.7× 64 491
Rama Al Hamed France 9 308 0.9× 223 0.8× 236 0.9× 71 0.5× 56 0.7× 11 487
Loredana Santo United States 9 456 1.3× 326 1.1× 383 1.4× 45 0.3× 59 0.7× 23 633
Rapp Mj France 6 246 0.7× 184 0.6× 153 0.6× 104 0.8× 77 1.0× 9 421
Ka Lung Wu Belgium 14 344 1.0× 361 1.3× 287 1.1× 232 1.8× 210 2.7× 39 708
Yoshiaki Kuroda Japan 12 222 0.6× 161 0.6× 204 0.8× 46 0.3× 51 0.6× 36 403
Natalia Tovar Spain 16 370 1.0× 180 0.6× 394 1.5× 55 0.4× 100 1.3× 55 554
D Borrego Spain 7 342 1.0× 155 0.5× 186 0.7× 47 0.4× 105 1.3× 11 414

Countries citing papers authored by M.V. Mateos

Since Specialization
Citations

This map shows the geographic impact of M.V. Mateos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.V. Mateos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.V. Mateos more than expected).

Fields of papers citing papers by M.V. Mateos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.V. Mateos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.V. Mateos. The network helps show where M.V. Mateos may publish in the future.

Co-authorship network of co-authors of M.V. Mateos

This figure shows the co-authorship network connecting the top 25 collaborators of M.V. Mateos. A scholar is included among the top collaborators of M.V. Mateos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.V. Mateos. M.V. Mateos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chim, Chor Sang, Shaji Kumar, Robert Z. Orlowski, et al.. (2017). Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond. Leukemia. 32(2). 252–262. 219 indexed citations
2.
Mateos, M.V., Michèle Cavo, Louis M. Fink, et al.. (2017). Patient Characteristics, Skeletal Related Events (SRE) And Renal Impairment (RI) In Patients With Multiple Myeloma (MM): A Patient Chart Audit In EU5. Value in Health. 20(9). A413–A413. 2 indexed citations
3.
Yong, Kwee, Michel Delforge, Christoph Driessen, et al.. (2015). MULTIPLE MYELOMA MANAGEMENT: OUTCOMES IN REAL-WORLD PRACTICE. Haematologica. 100. 252–253. 1 indexed citations
4.
Raab, Marc‐Steffen, Michèle Cavo, Michel Delforge, et al.. (2015). MULTIPLE MYELOMA MANAGEMENT: PRACTICE PATTERNS ACROSS EUROPE. Haematologica. 100. 251–252. 3 indexed citations
5.
López‐Corral, Lucía, M.V. Mateos, Luís A. Corchete, et al.. (2012). Genomic analysis of high-risk smoldering multiple myeloma. Haematologica. 97(9). 1439–1443. 39 indexed citations
6.
Lahuerta, Juan José, M.V. Mateos, Joaquín Martínez‐López, et al.. (2010). Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study. Haematologica. 95(11). 1913–1920. 70 indexed citations
7.
Spencer, Andrew, Sagar Lonial, M.V. Mateos, et al.. (2009). Panobinostat plus lenalidomide and dexamethasone phase I trial in multiple myeloma (MM). Journal of Clinical Oncology. 27(15_suppl). 8542–8542. 13 indexed citations
8.
9.
Alvarez, Iván, Anna Sureda, Marı́a Dolores Caballero, et al.. (2006). Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol. Biology of Blood and Marrow Transplantation. 12(2). 172–183. 100 indexed citations
10.
Persona, Ernesto Pérez, María‐Belén Vídriales, Gema Mateo, et al.. (2006). New Criteria To Identify Risk of Progression in Monoclonal Gammopathy of Uncertain Significance: Multiparametric Flow Cytometry Analysis of Bone Marrow Plasma Cells.. Blood. 108(11). 3517–3517. 1 indexed citations
11.
12.
Martı́n, Alejandro, Marı́a Dolores Caballero, Josè Antonio Pérez-Simón, et al.. (2004). Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study. Bone Marrow Transplantation. 34(8). 675–682. 6 indexed citations
13.
Pérez-Simón, Josè Antonio, Ignacio Escobar, Jesús Martı́nez, et al.. (2003). Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation. Bone Marrow Transplantation. 33(2). 183–187. 19 indexed citations
14.
González, Marcos, David González, Ricardo López‐Pérez, et al.. (1999). Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies.. PubMed. 84(9). 779–84. 35 indexed citations
15.
García‐Sánz, Ramón, Ricardo López‐Pérez, Anton W. Langerak, et al.. (1999). Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma.. PubMed. 84(4). 328–35. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafael Martínez Breakdown of academic impact, for papers by Τατιάνα Τζένου Breakdown of academic impact, for papers by Neil Palmisiano Breakdown of academic impact, for papers by Rama Al Hamed Breakdown of academic impact, for papers by Loredana Santo Breakdown of academic impact, for papers by Rapp Mj Breakdown of academic impact, for papers by Ka Lung Wu Breakdown of academic impact, for papers by Yoshiaki Kuroda Breakdown of academic impact, for papers by Natalia Tovar Breakdown of academic impact, for papers by D Borrego
Rankless by CCL
2026